{"action":[{"action":[{"action":[{"action":[{"action":[{"definitionCanonical":"#1111","extension":[{"extension":[{"url":"day","valueInteger":1},{"url":"day","valueInteger":8}],"url":"http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle"}],"id":"action-1","textEquivalent":"Gemcitabine 1250 mg/m² IV over 30 minutes on days 1 and 8"},{"definitionCanonical":"#2222","extension":[{"extension":[{"url":"day","valueInteger":1}],"url":"http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle"}],"id":"action-2","relatedAction":[{"relationship":"concurrent-with-start","targetId":"action-1"}],"textEquivalent":"CARBOplatin AUC 5 IV over 30 minutes on Day 1"}],"id":"cycle-definition-1","textEquivalent":"21-day cycle for 6 cycles","timingTiming":{"repeat":{"count":6,"duration":21,"durationUnit":"d"}}}],"groupingBehavior":"sentence-group","selectionBehavior":"exactly-one"}],"selectionBehavior":"all"}],"selectionBehavior":"exactly-one"}],"approvalDate":"2016-07-27","author":[{"name":"Lee Surprenant"}],"contact":[{"telecom":[{"system":"url"}]}],"contained":[{"dosage":[{"doseAndRate":[{"doseQuantity":{"unit":"mg/m²","value":1250},"type":{"coding":[{"code":"ordered","display":"Ordered","system":"http://terminology.hl7.org/CodeSystem/dose-rate-type"}]}}],"route":{"text":"IV"},"text":"1250 mg/m² IV over 30 minutes","timing":{"repeat":{"duration":30,"durationUnit":"min"}}}],"id":"1111","productCodeableConcept":{"coding":[{"code":"12574","display":"gemcitabine","system":"http://www.nlm.nih.gov/research/umls/rxnorm"}],"text":"gemcitabine"},"resourceType":"ActivityDefinition","status":"draft"},{"dosage":[{"doseAndRate":[{"doseQuantity":{"extension":[{"url":"http://example.org/fhir/AUC-dose","valueInteger":5}]},"type":{"coding":[{"code":"ordered","display":"Ordered","system":"http://terminology.hl7.org/CodeSystem/dose-rate-type"}]}}],"route":{"text":"IV"},"text":"AUC 5 IV over 30 minutes","timing":{"repeat":{"duration":30,"durationUnit":"min"}}}],"id":"2222","productCodeableConcept":{"coding":[{"code":"40048","display":"Carboplatin","system":"http://www.nlm.nih.gov/research/umls/rxnorm"}],"text":"CARBOplatin"},"resourceType":"ActivityDefinition","status":"draft"}],"copyright":"All rights reserved.","description":"Gemcitabine/CARBOplatin","experimental":true,"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"cds"}],"id":"KDN5","identifier":[{"system":"http://example.org/ordertemplates","value":"KDN5"}],"lastReviewDate":"2016-07-27","name":"GemcitabineCARBOplatin","publisher":"HL7 International / Clinical Decision Support","relatedArtifact":[{"display":"NCCN Guidelines for Kidney Cancer. V.2.2016","document":{"url":"http://www.example.org/professionals/physician_gls/PDF/kidney.pdf"},"type":"derived-from"},{"_type":{"extension":[{"url":"http://example.org/fhir/regimenReferenceType","valueCode":"a"}]},"citation":"Oudard S, et al. J Urol. 2007;177(5):1698-702","document":{"url":"http://www.ncbi.nlm.nih.gov/pubmed/17437788"},"type":"citation"}],"resourceType":"PlanDefinition","status":"draft","text":{"div":"
\n \n \n National Comprehensive Cancer Network \n \n | \n \n \n \n Chemotherapy Order Template\n \nKidney Cancer\n \nGemcitabine/CARBOplatin\n \n | \n \n KDN5 | \n \n
\n \n INDICATION:\n \nMetastatic or Relapsed – Collecting Duct/Medullary Subtypes \n \n | \n \n \n \n REFERENCES:\n \n
| \n \n \n \n NCCN SUPPORTIVE CARE:\n \n
| \n \n
\n \n 21-day cycle for 6 cycles\n \n
\n \n